Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability

Journal of Women's Health

Volumn 25, Issue 5, 2016, Pages 489-497

  Racey, C Sarai ^a   Gesink, Dionne C ^a   Burchell, Ann N ^a,b   Trivers, Suzanne ^c   Wong, Tom ^a,d   Rebbapragada, Anu ^e  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Mount Forest Family Health Team   (Canada)

^d HEALTH CANADA   (Canada)

^e DYNACARE LABORATORIES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN;

ADULT; AGED; ARTICLE; CANADA; CANCER SCREENING; CERVICAL CANCER SCREENING; CONCURRENT SEXUAL PARTNERSHIP; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN PAPILLOMAVIRUS TESTING; INFECTION RISK; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION; SAMPLING; SCREENING TEST; SELF CARE; SELF COLLECTED SAMPLING; SMOKING; UTERINE CERVIX CANCER; VIRUS EXAMINATION; EARLY CANCER DIAGNOSIS; ISOLATION AND PURIFICATION; MASS SCREENING; ONTARIO; OUTCOME ASSESSMENT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ADULT; AGED; CANADA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RURAL POPULATION; SELF CARE; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84969639983     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2015.5348     Document Type: Article

References (46)

1. Dickinson JA, Stankiewicz A, Popadiuk C, Pogany L, Onysko J, Miller AB. Reduced cervical cancer incidence and mortality in Canada: National data from 1932-2006. BMC Public Health 2012;12:992.
2. Canadian Cancer Statistics 2014. Canadian Cancer Society. Toronto, Ontario, 2014.
3. Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: Evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008;100:622-629.
4. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: Systematic review and metaanalysis. Prev Med 2007;45:93-106.
5. Ontario Cervical Screening Program 2012 Report. Toronto, Canada: Cancer Care Ontario, 2014.
6. Gesink D, Mihic A, Antal J, et al. Who are the under-and never-screened for cancer in Ontario: A qualitative investigation. BMC Public Health 2014;14:495.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
8. Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30 Suppl 5:F88-F99.
9. Mayrand M-H, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357:1579-1588.
10. Murphy J, Kennedy EB, Dunn S, et al. HPV testing in primary cervical screening: A systematic review and metaanalysis. J Obstet Gynaecol Can 2012;34:443-452.
11. Elfstrom KM, Smelov V, Johansson AL, et al. Long term duration of protective effect for HPV negative women: Follow-up of primary HPV screening randomised controlled trial. BMJ 2014;348:g130.
12. Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPVbased screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. Lancet 2014;383:524-532.
13. Franco EL, Mahmud SM, Tota J, Ferenczy A, Coutlee F. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: The need for a paradigm change. Arch Med Res 2009;40:478-485.
14. Burger EA, Ortendahl JD, Sy S, Kristiansen IS, Kim JJ. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway. Br J Cancer 2012;106:1571-1578.
15. Vijayaraghavan A, Efrusy MB, Mayrand M-H, Santas CC, Goggin P. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada. Can J Public Health 2010;101:220-225.
16. Moyer VA. Screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2012;156:880-891.
17. Canadian Task Force on Preventive Health Care. Recommendations on screening for cervical cancer. CMAJ 2013;185:35-45.
18. Murphy J, Kennedy EB, Dunn S, et al. Cervical screening: A guideline for clinical practice in Ontario. J Obstet Gynaecol Can 2012;34:453-458.
19. Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015;136:189-197.
20. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006;82:337-339.
21. Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: A meta-analysis. Sex Transm Infect 2005;81:207-212.
22. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and metaanalysis. Gynecol Oncol 2007;105:530-535.
23. Szarewski A, Cadman L, Mallett S, et al. Human papillomavirus testing by self-sampling: Assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007;14: 34-42.
24. Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus cliniciancollected samples: A meta-analysis. Lancet Oncol 2014;15: 172-183.
25. Arbyn M, Castle PE. Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol Biomarkers Prev 2015;24:769-772.
26. Coronado GD, Thompson B, Koepsell TD, Schwartz SM, McLerran D. Use of Pap test among Hispanics and non-Hispanicwhites in a rural setting. PrevMed 2004;38:713-722.
27. Waller J, Bartoszek M, Marlow L, Wardle J. Barriers to cervical cancer screening attendance in England: A population-based survey. J Med Screen 2009;16:199-204.
28. Darlin L, Borgfeldt C, Forslund O, et al. Comparison of use of vaginalHPVself-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol 2013;58:155-160.
29. Racey CS, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: A systematic review and meta-analysis. Can J Public Health 2013;104:e159-e166.
30. Ogilvie G, Krajden M, Maginley J, et al. Feasibility of selfcollection of specimens for human papillomavirus testing in hard-to-reach women. Can Med Assoc J 2007;177: 480-483.
31. Johnston GM, Boyd CJ, MacIsaac MA. Community-based cultural predictors of Pap smear screening in Nova Scotia. Can J Public Health 2004;95:95-98.
32. Studts CR, Tarasenko YN, Schoenberg NE. Barriers to cervical cancer screening among middle-aged and older rural Appalachian women. J Community Health 2013;38:500-512.
33. Franco EL, Cuzick J, Hildesheim A, de Sanjose S. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 2006;24 Suppl 3:S3/171-177.
34. Huynh J, Howard M, Lytwyn A. Self-collection for vaginal human papillomavirus testing: Systematic review of studies asking women thier perceptions. J 2010;14:356-362.
35. Statistics Canada. Wellington North, TP, Ontario (Code 3523050). National Household Survey (NHS) Profile. 2011 National Household Survey. Ottawa, Canada: Statistics Canada, 2013.
36. Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: Comparison of two self-sampling modalities. J Womens Health (Larchmt) 2011;20:397-402.
37. Zehbe I, Moeller H, Severini A, et al. Feasibility of selfsampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: A pilot study. BMJ Open 2011;1:e000030.
38. Sandfort JR, Pleasant A. Knowledge, attitudes, and informational behaviors of college students in regard to the human papillomavirus. J Am Coll Health 2009;58:141-149.
39. Zubach V, Smart G, Ratnam S, Severini A. Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types. J Clin Microbiol 2012;50:460-464.
40. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
41. Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ 2011;2:53-55.
42. Ogilvie GS, Mitchell S, Sekikubo M, et al. Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. Int J Gynaecol Obstet 2013;122:118-123.
43. Rosenbaum AJ, Gage JC, Alfaro KM, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynaecol Obstet 2014;126:156-160.
44. Schmeink CE, Bekkers RL, Massuger LF, Melchers WJ. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol 2011;21:139-153.
45. Vanderpool RC, Jones MG, Stradtman LR, Smith JS, Crosby RA. Self-collecting a cervico-vaginal specimen for cervical cancer screening: An exploratory study of acceptability among medically underserved women in rural Appalachia. Gynecol Oncol 2014;132 Suppl 1:S21-S25.
46. Forrest S, McCaffery K, Waller J, et al. Attitudes to selfsampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen 2004;11:85-88.